Inflammatory Bowel Disease — Diagnostic and Therapeutic Strategies

Abstract

From the Contents List of principal contributors List of chairpersons Preface SECTION I: MECHANISMS OF INFLAMMATORY BOWEL DISEASE: 1st SESSION.- 1 State-of-the-Art Lecture: The multifactorial pathogenesis of inflammatory bowel disease.- 2 CD1d: at the cusp of innate and adaptive immunity in regulating mucosal inflammation.- 3 Control of mucosal immune responses by transforming growth factor-beta.- 4 Immunoregulation: Crohn's disease versus ulcerative colitis.- 5 Role of Toll-like receptors in inflammatory bowel diseases.- 6 Animal models in inflammatory bowel disease.- 7 Epidemiology of inflammatory bowel disease in Russia.- SECTION II: MECHANISMS OF INFLAMMATORY BOWEL DISEASE: 2nd SESSION.- 8 State-of-the-Art Lecture: Genetics and genomics: implications for clinical practice.- 9 Genetic factors in the inflammatory bowel disease.- 10 Genotype-based classification of inflammatory bowel disease phenotype.- 11 Role of the intestinal barrier in inflammatory bowel disease.- SECTION III: MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: 1st SESSION.- 12 Histological evaluation of activity of the ulcerative colitis in its initial stage of development.- 13 Crohn's disease of the small intestine: versions of clinical picture and problems of differential diagnosis.- 14 Distal colitis as a special pattern of ulcerative colitis.- 15 Implications of dysplasia in the prevention of ulcerative colitis-associated colo.- 16 The chemopreventive effect of aminosalicylates.- 17 The role of antibiotics and probiotics in Crohn's disease.- SECTION IV: MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: 2nd SESSION.- 18 Indications for use of infliximab in inflammatory bowel disease.- 19 Therapy of inflammatory bowel disease: step-up or top-down.- 20 State of the Art Lecture: Emerging biologic therapies.- 21 Surgical treatment of complications of Crohn's disease.- 22 Surgical treatment of ulcerative colitis.- Index